HealthcareServices

Revenue of the Near-Patient Molecular Solutions Market Predicted to Achieve $7.17 Billion by 2030, Driven by 9.5% CAGR

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the near-patient molecular solutions market from 2026–2035 with trusted insights from The Business Research Company

What is the estimated market size of the Near-Patient Molecular Solutions Market by the end of 2030?

The near-patient molecular solutions market has experienced robust expansion over recent years. Projections indicate a rise from $4.54 billion in 2025 to $4.99 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.8%. Historically, this growth has stemmed from factors such as the expansion of molecular diagnostic techniques, the demand for rapid test turnaround times, the decentralization of laboratory services, an increase in outpatient diagnostic settings, and the adoption of portable diagnostic instruments.

The near-patient molecular solutions market is anticipated to show significant expansion over the next few years, with its size expected to reach $7.17 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.5%. This growth in the projection period stems from a heightened focus on personalized medicine, an escalating need for home and remote diagnostic options, advancements in miniaturized molecular platform technologies, the broadening of infectious disease surveillance efforts, and integration with digital health ecosystems. Prominent trends for the forecast period include the increasing adoption of point-of-care molecular testing devices, a rising demand for rapid infectious disease diagnostics, the growing integration of portable PCR platforms, an expansion of decentralized diagnostic infrastructure, and an enhanced emphasis on the accuracy of near-patient testing.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30333&type=smp

What Drivers Are Shaping Future Opportunities In The Near-Patient Molecular Solutions Market?

The expanding need for home-based point-of-care devices is anticipated to drive the future expansion of the near patient molecular solutions market. These devices are diagnostic systems used by patients or non-laboratory individuals at or close to home, facilitating sample collection, analysis, or result interpretation away from a traditional central laboratory and near the point of care. The increased demand for home-based point-of-care devices stems from consumers’ growing preference for convenient, quick, and accessible health monitoring beyond conventional healthcare environments. Near-patient molecular solutions enhance home-based point-of-care devices by offering precise, fast, and portable molecular diagnostic tools suitable for reliable use outside typical laboratory environments. For example, in February 2023, the US Food & Drug Administration (FDA), a US government agency, issued a 2023 COVID-19 testing update indicating one Emergency Use Authorization (EUA) for a molecular prescription at-home test, two EUAs for antigen prescription at-home tests, 26 EUAs for antigen over-the-counter (OTC) at-home tests, and four EUAs for molecular OTC at-home tests. Consequently, the increasing demand for home-based point-of-care devices is fueling the expansion of the near patient molecular solutions market.

Which Segments Are Gaining Traction In The Near-Patient Molecular Solutions Market?

The near-patient molecular solutions market covered in this report is segmented –

1) By Product Type: Infectious Diseases Testing Kits, Urinalysis Testing Kits, Tumor Or Cancer Markers, Pregnancy And Fertility, Hematology Testing Kits, Glucose Monitoring Kits, Drugs-Of-Abuse Testing Kits, Coagulation Monitoring Kits, Cardiometabolic Monitoring Kits, Other Product Types

2) By Technology: Polymerase Chain Reaction (PCR)-Based, Genetic Sequencing-Based, Hybridization-Based, Microarray-Based

3) By End-User: Hospitals And Clinics, Ambulatory Care Centers, Research Laboratories, Home Care Settings, Other End-Users

Subsegments:

1) By Infectious Diseases Testing Kits: Hepatitis Testing Kits, Human Immunodeficiency Virus Testing Kits, Influenza Testing Kits, COVID-19 Testing Kits

2) By Urinalysis Testing Kits: Protein Testing Kits, Glucose Testing Kits, Ketone Testing Kits, Nitrite Testing Kits

3) By Tumor Or Cancer Markers: Prostate-Specific Antigen Testing Kits, Carcinoembryonic Antigen Testing Kits, Cancer Antigen 125 Testing Kits, Alpha-Fetoprotein Testing Kits

4) By Pregnancy And Fertility: Ovulation Testing Kits, Early Pregnancy Testing Kits, Digital Pregnancy Testing Kits, Home Fertility Monitoring Kits

5) By Hematology Testing Kits: Complete Blood Count Testing Kits, Hemoglobin Testing Kits, White Blood Cell Count Testing Kits, Platelet Count Testing Kits

6) By Glucose Monitoring Kits: Self-Monitoring Blood Glucose Kits, Continuous Glucose Monitoring Kits, Non-Invasive Glucose Testing Kits, Disposable Glucose Test Strips

7) By Drugs-Of-Abuse Testing Kits: Urine Drug Testing Kits, Saliva Drug Testing Kits, Hair Drug Testing Kits, Blood Drug Testing Kits

8) By Coagulation Monitoring Kits: Prothrombin Time Testing Kits, International Normalized Ratio Testing Kits, Activated Partial Thromboplastin Time Testing Kits, D-Dimer Testing Kits

9) By Cardiometabolic Monitoring Kits: Cholesterol Testing Kits, Triglyceride Testing Kits, Low-Density Lipoprotein Testing Kits, High-Density Lipoprotein Testing Kits

10) By Other Product Types: Allergy Testing Kits, Thyroid Function Testing Kits, Vitamin Deficiency Testing Kits, Liver Function Testing Kits

Which Trends Are Expected To Influence The Near-Patient Molecular Solutions Market In The Upcoming Years?

Leading firms in the near-patient molecular solutions market are prioritizing the integration of technological innovations, such as isothermal nucleic acid amplification, to improve testing efficiency, portability, and diagnostic precision. Isothermal nucleic acid amplification, an advanced molecular diagnostic technique, functions by multiplying target nucleic acid sequences at a steady temperature. This eliminates the necessity for thermal cycling, which is required in conventional polymerase chain reaction (PCR), thereby facilitating rapid, sensitive, and compact molecular analyses. For instance, in June 2023, Cue Health Inc., a US-based healthcare technology company specializing in molecular diagnostics, secured FDA marketing authorization for their Cue COVID-19 Molecular Test. This diagnostic device, based on isothermal amplification, was designed for the at-home and point-of-care detection of SARS-CoV-2 RNA. The system features a single-use cartridge, a Bluetooth-enabled reader, and a mobile app interface that guides users through the testing process and delivers molecular results in about 20 minutes. The Cue COVID-19 molecular test enhances accessibility to accurate molecular-level diagnostics, shortens turnaround time, and supports real-time health decision-making outside traditional laboratory environments.

Who Are The Core Companies Influencing Trends In The Near-Patient Molecular Solutions Market?

Major companies operating in the near-patient molecular solutions market are Bosch Healthcare Solutions GmbH, Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Hologic Inc., bioMérieux SA, Sysmex Corporation, QuidelOrtho Corporation, QIAGEN NV, DiaSorin SpA, OraSure Technologies Inc., Molbio Diagnostics Pvt Ltd, Cue Health Inc., Biocartis Group NV, Vela Diagnostics Pte Ltd, Co-Diagnostics Inc., Hyris Ltd, Genedrive plc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/global-near-patient-molecular-solutions-market-report

Which Region Is Expected To Experience The Fastest Growth In The Near-Patient Molecular Solutions Market?

North America was the largest region in the near-patient molecular solutions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the near-patient molecular solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Near-Patient Molecular Solutions Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30333&type=smp

Browse Through More Reports Similar to the Global Near-Patient Molecular Solutions Market 2026, By The Business Research Company

Small Molecule Drug Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/small-molecule-drug-discovery-global-market-report

Non Therapeutic Biomolecules Market Report 2026

https://www.thebusinessresearchcompany.com/report/non-therapeutic-biomolecules-global-market-report

Clinical Chemistry Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-chemistry-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795